Your browser doesn't support javascript.
loading
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype.
Zhou, Yuan; Claflin, Suzi B; Stankovich, Jim; van der Mei, Ingrid; Simpson, Steve; Roxburgh, Richard H; Kalincik, Tomas; Blizzard, Leigh; Lugaresi, Alessandra; Alroughani, Raed; Sajedi, Seyed Aidin; Butzkueven, Helmut; Pucci, Eugenio; Spitaleri, Daniele LA; Granella, Franco; Cristiano, Edgardo; Yamout, Bassem; Hughes, Stella; Gouider, Riadh; Sánchez Menoyo, José Luis; Olascoaga, Javier; McGuigan, Chris; Shaw, Cameron; Kermode, Allan G; Kasa, Krisztian; Al-Harbi, Talal; Altintas, Ayse; Laureys, Guy; Fragoso, Yara; Hardy, Todd A; Csepany, Tunde; Sirbu, Carmen-Adella; Decoo, Danny; Sas, Attila; Alvarez-Cermeño, Jose C; Kotkata, Karim; Millán-Pascual, Jorge; Taylor, Bruce V.
Afiliação
  • Zhou Y; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Claflin SB; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Stankovich J; Department of Neuroscience, Monash University, Melbourne, VIC, Australia.
  • van der Mei I; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Simpson S; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia/Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia.
  • Roxburgh RH; Centre for Brain Research Neurogenetics Clinic, The University of Auckland, Auckland, New Zealand.
  • Kalincik T; CORe, Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia/Department of Neurology, The University of Melbourne, Melbourne, VIC, Australia.
  • Blizzard L; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
  • Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy/Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
  • Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
  • Sajedi SA; Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Butzkueven H; Department of Neuroscience, Monash University, Melbourne, VIC, Australia.
  • Pucci E; Generale Provinciale Macerata, Macerata, Italy.
  • Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.
  • Granella F; University of Parma, Parma, Italy.
  • Cristiano E; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Yamout B; American University of Beirut Medical Center, Beirut, Lebanon.
  • Hughes S; Craigavon Area Hospital, Craigavon, UK.
  • Gouider R; Razi Hospital, Tunis, Tunisia.
  • Sánchez Menoyo JL; Hospital de Galdakao-Usansolo, Bizkaia, Spain.
  • Olascoaga J; Hospital Donostia, Gipuzkoa, Spain.
  • McGuigan C; St. Vincent's University Hospital, Dublin, Ireland.
  • Shaw C; Geelong Hospital, Geelong, VIC, Australia.
  • Kermode AG; Perron Institute for Neurological and Translational Sciences, Nedlands, WA, Australia.
  • Kasa K; Jahn Ferenc Teaching Hospital, Budapest, Hungary.
  • Al-Harbi T; King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
  • Altintas A; Department of Neurology, School of Medicine, Koç University, Istanbul, Turkey.
  • Laureys G; University Hospital Ghent, Gent, Belgium.
  • Fragoso Y; Universidade Metropolitana de Santos, Santos, Brazil.
  • Hardy TA; University of Parma, Parma, Italy/Concord Repatriation General Hospital, Sydney, NSW, Australia.
  • Csepany T; Department of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Sirbu CA; Central University Emergency Military Hospital, Bucharest, Romania.
  • Decoo D; AZ Alma, Eeklo, Belgium.
  • Sas A; Borsod-Abaúj-Zemplén County Hospital, Miskolc, Hungary.
  • Alvarez-Cermeño JC; Ramon y Cajal University Hospital, Madrid, Spain.
  • Kotkata K; Alexandria University Student Hospital, Alexandria, Egypt.
  • Millán-Pascual J; Hospital Mancha Centro, Real, Spain.
  • Taylor BV; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Mult Scler ; 26(13): 1765-1774, 2020 11.
Article em En | MEDLINE | ID: mdl-31668127
ABSTRACT

BACKGROUND:

The Multiple Sclerosis Severity Score (MSSS) is a widely used measure of the disability progression rate. However, the global MSSS may not be the best basis for comparison between all patient groups.

OBJECTIVE:

We evaluated sex-specific and onset phenotype-specific MSSS matrices to determine if they were more effective than the global MSSS as a basis for comparison within these subsets.

METHODS:

Using a large international dataset of multiple sclerosis (MS) patient records and the original MSSS algorithm, we constructed global, sex-specific and onset phenotype-specific MSSS matrices. We compared matrices using permutation analysis.

RESULTS:

Our final dataset included 30,203 MS cases, with 28.9% males and 6.5% progressive-onset cases. Our global MSSS matrix did not differ from previously published data (p > 0.05). The progressive-onset-specific matrix differed significantly from the relapsing-onset-specific matrix (p < 0.001), with lower MSSS attributed to cases with the same Expanded Disability Status Score (EDSS) and disease duration. When evaluated with a simulation, using an onset-specific MSSS improved statistical power in mixed cohorts. There were no significant differences by sex.

CONCLUSION:

The differences in the disability accrual rate between progressive- and relapsing-onset MS have a significant effect on MSSS. An onset-specific MSSS should be used when comparing the rate of disability progression among progressive-onset cases and for mixed cohorts.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Male Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Male Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália